Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.35
ERFSF's Cash to Debt is ranked higher than
50% of the 182 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 10.63 vs. ERFSF: 0.35 )
ERFSF' s 10-Year Cash to Debt Range
Min: 0.25   Max: 1.36
Current: 0.35

0.25
1.36
Equity to Asset 0.32
ERFSF's Equity to Asset is ranked higher than
50% of the 169 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.68 vs. ERFSF: 0.32 )
ERFSF' s 10-Year Equity to Asset Range
Min: 0.22   Max: 0.35
Current: 0.32

0.22
0.35
F-Score: 4
Z-Score: 3.70
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.70
ERFSF's Operating margin (%) is ranked higher than
82% of the 168 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.31 vs. ERFSF: 9.70 )
ERFSF' s 10-Year Operating margin (%) Range
Min: 1.6   Max: 12.76
Current: 9.7

1.6
12.76
Net-margin (%) 6.31
ERFSF's Net-margin (%) is ranked higher than
79% of the 168 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.95 vs. ERFSF: 6.31 )
ERFSF' s 10-Year Net-margin (%) Range
Min: -1.76   Max: 6.68
Current: 6.31

-1.76
6.68
ROE (%) 17.53
ERFSF's ROE (%) is ranked higher than
92% of the 161 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.30 vs. ERFSF: 17.53 )
ERFSF' s 10-Year ROE (%) Range
Min: -5.56   Max: 18.83
Current: 17.53

-5.56
18.83
ROA (%) 5.69
ERFSF's ROA (%) is ranked higher than
80% of the 173 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.69 vs. ERFSF: 5.69 )
ERFSF' s 10-Year ROA (%) Range
Min: -1.71   Max: 5.69
Current: 5.69

-1.71
5.69
ROC (Joel Greenblatt) (%) 48.36
ERFSF's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 172 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 5.52 vs. ERFSF: 48.36 )
ERFSF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.59   Max: 63.84
Current: 48.36

7.59
63.84
Revenue Growth (%) 16.60
ERFSF's Revenue Growth (%) is ranked higher than
93% of the 134 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 6.40 vs. ERFSF: 16.60 )
ERFSF' s 10-Year Revenue Growth (%) Range
Min: 8.2   Max: 38.1
Current: 16.6

8.2
38.1
EBITDA Growth (%) 37.90
ERFSF's EBITDA Growth (%) is ranked higher than
95% of the 115 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 6.00 vs. ERFSF: 37.90 )
ERFSF' s 10-Year EBITDA Growth (%) Range
Min: -0.8   Max: 64.4
Current: 37.9

-0.8
64.4
» ERFSF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with ERFSF



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 48.30
ERFSF's P/E(ttm) is ranked higher than
51% of the 93 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 24.90 vs. ERFSF: 48.30 )
ERFSF' s 10-Year P/E(ttm) Range
Min: 15.49   Max: 135.83
Current: 48.3

15.49
135.83
P/B 7.97
ERFSF's P/B is ranked lower than
60% of the 155 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.69 vs. ERFSF: 7.97 )
ERFSF' s 10-Year P/B Range
Min: 1.93   Max: 10.96
Current: 7.97

1.93
10.96
P/S 3.05
ERFSF's P/S is ranked higher than
68% of the 170 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.47 vs. ERFSF: 3.05 )
ERFSF' s 10-Year P/S Range
Min: 0.66   Max: 3.55
Current: 3.05

0.66
3.55
PFCF 50.91
ERFSF's PFCF is ranked lower than
54% of the 81 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.94 vs. ERFSF: 50.91 )
ERFSF' s 10-Year PFCF Range
Min: 7.93   Max: 407.5
Current: 50.91

7.93
407.5
EV-to-EBIT 33.97
ERFSF's EV-to-EBIT is ranked lower than
57% of the 109 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 19.60 vs. ERFSF: 33.97 )
ERFSF' s 10-Year EV-to-EBIT Range
Min: 10.3   Max: 92.7
Current: 33.97

10.3
92.7
PEG 2.08
ERFSF's PEG is ranked higher than
77% of the 53 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.92 vs. ERFSF: 2.08 )
ERFSF' s 10-Year PEG Range
Min: 0.6   Max: 9.1
Current: 2.08

0.6
9.1
Shiller P/E 120.51
ERFSF's Shiller P/E is ranked lower than
55% of the 53 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 34.47 vs. ERFSF: 120.51 )
ERFSF' s 10-Year Shiller P/E Range
Min: 37.76   Max: 129.34
Current: 120.51

37.76
129.34

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 4.30
ERFSF's Price/DCF (Projected) is ranked lower than
57% of the 76 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.80 vs. ERFSF: 4.30 )
ERFSF' s 10-Year Price/DCF (Projected) Range
Min: 1.55   Max: 4.53
Current: 4.3

1.55
4.53
Price/Median PS Value 1.73
ERFSF's Price/Median PS Value is ranked lower than
57% of the 147 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.15 vs. ERFSF: 1.73 )
ERFSF' s 10-Year Price/Median PS Value Range
Min: 0.46   Max: 1.37
Current: 1.73

0.46
1.37
Price/Peter Lynch Fair Value 2.09
ERFSF's Price/Peter Lynch Fair Value is ranked higher than
70% of the 30 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.21 vs. ERFSF: 2.09 )
ERFSF' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.02   Max: 6.75
Current: 2.09

1.02
6.75
Earnings Yield (Greenblatt) 2.90
ERFSF's Earnings Yield (Greenblatt) is ranked higher than
56% of the 122 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.70 vs. ERFSF: 2.90 )
ERFSF' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 9.7
Current: 2.9

1.1
9.7
Forward Rate of Return (Yacktman) 24.17
ERFSF's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 138 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.75 vs. ERFSF: 24.17 )
ERFSF' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9   Max: 48
Current: 24.17

9
48

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research
Compare:LH, ALR, DGX, LIFE, ENZ » details
Traded in other countries:ERF.France, ESF.Germany
Eurofins Scientific Group S.A. provides analytical testing & support services. It services include food & feed testing, pharma services, pharma product testing, forensics & applied genetics, among others.
» More Articles for OTCPK:ERFSF

Headlines

Articles On GuruFocus.com
No related article found.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide